(Q44489371)
Statements
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer (English)
Miloslava Vaculikova
Jiri Petera
Petr Prosvic
Zdenek Zoul
Lubos Rydel
Milos Brodak
Zbynek Veselsky
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference